Smartphone maker HTC Corp (宏達電) has set its sights on earning an operating license from the Food and Drug Administration to commercialize a new medical virtual-reality (VR) product in the first quarter of next year.
Dubbed Surgical Theater, the VR product could begin to be adopted in clinical use and provide HTC with new revenue streams from the healthcare sector, the company said at a news conference yesterday.
The company also announced that it has sold Taipei Medical University its latest VR offering, 3D Organon, a bundle of 10 Vive Pro VR headsets that provide visualized anatomy information for education.
Photo by Kao Shih-ching, taipei Times
Medical students usually learn human anatomy from 2D models and diagrams in textbooks, or from donated cadavers, which are often in short supply, university Department of Anatomy professor Chang Hung-ming (張宏名) told the Taipei Times.
With the VR teaching system, students can see a computerized simulation that more clearly depicts human anatomy, especially the nervous system, whose components are thin and mostly hidden behind muscles and cavities, Chang said.
A 360o view allows users to see the human body from all angles to better understand how everything is connected, and they can also peel back layers or isolate 4,000 body parts to have a specific view, HTC healthcare division DeepQ director Jerry Cheng (鄭志偉) said.
“Users can even go through the virtual body to have a clear look inside at parts such as the spine and cavities,” he said.
However, it is hard for a VR system to substitute for “silent teachers” (大體老師) — people who have donated their bodies to medical schools — as “students cannot touch or feel the elasticity of muscles in virtual reality,” Chang said.
Besides Taipei Medical University, HTC has also sold 3D Organon to Tri-Service General Hospital and Taipei Municipal Wanfang Hospital, which plan to use the product for shared decisionmaking with patients, Cheng said.
While the firm has begun marketing 3D Organon, which costs about NT$100,000 per unit, HTC said it has also applied for a license for Surgical Theater, which would cost significantly more.
The company has received three medical appliance licenses from the US Food and Drug Administration for Surgical Theater, which provides accurate information that can even be used to help surgeons navigate operations, Cheng said.
As HTC has already conducted clinical trials in the US, it expects to receive approval from the Taiwanese agency by the first quarter of next year, Cheng said, adding that it would market the product to domestic hospitals first and expects to see revenue from the healthcare sector soar.
COMPETITION: AMD, Intel and Qualcomm are unveiling new laptop and desktop parts in Las Vegas, arguing their technologies provide the best performance for AI workloads Advanced Micro Devices Inc (AMD), the second-biggest maker of computer processors, said its chips are to be used by Dell Technologies Inc for the first time in PCs sold to businesses. The chipmaker unveiled new processors it says would make AMD-based PCs the best at running artificial intelligence (AI) software. Dell has decided to use the chips in some of its computers aimed at business customers, AMD executives said at CES in Las Vegas on Monday. Dell’s embrace of AMD for corporate PCs — it already uses the chipmaker for consumer devices — is another blow for Intel Corp as the company
MediaTek Inc (聯發科) yesterday said it is teaming up with Nvidia Corp to develop a new chip for artificial intelligence (AI) supercomputers that uses architecture licensed from Arm Holdings PLC. The new product is targeting AI researchers, data scientists and students rather than the mass PC market, the company said. The announcement comes as MediaTek makes efforts to add AI capabilities to its Dimensity chips for smartphones and tablets, Genio family for the Internet of Things devices, Pentonic series of smart TVs, Kompanio line of Arm-based Chromebooks, along with the Dimensity auto platform for vehicles. MeidaTek, the world’s largest chip designer for smartphones
TECH PULL: Electronics heavyweights also attracted strong buying ahead of the CES, analysts said. Meanwhile, Asian markets were mixed amid Trump’s incoming presidency Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) shares yesterday closed at a new high in the wake of a rally among tech stocks on Wall Street on Friday, moving the TAIEX sharply higher by more than 600 points. TSMC, the most heavily weighted stock in the TAIEX, rose 4.65 percent to close at a new high of NT$1,125, boosting its market value to NT$29.17 trillion (US$888 billion) and contributing about 400 points to the TAIEX’s rise. The TAIEX ended up 639.41 points, or 2.79 percent, at 23,547.71. Turnover totaled NT$406.478 billion, Taiwan Stock Exchange data showed. The surge in TSMC follows a positive performance
FUTURE TECH: Nvidia CEO Jensen Huang would give the keynote speech at this year’s Consumer Electronics Show, which is also expected to highlight autonomous vehicles Gadgets, robots and vehicles imbued with artificial intelligence (AI) would once again vie for attention at the Consumer Electronics Show (CES) this week, as vendors behind the scenes would seek ways to deal with tariffs threatened by US president-elect Donald Trump. The annual Consumer Electronics Show opens formally in Las Vegas tomorrow, but preceding days are packed with product announcements. AI would be a major theme of the show, along with autonomous vehicles ranging from tractors and boats to lawn mowers and golf club trollies. “Everybody is going to be talking about AI,” Creative Strategies Inc analyst Carolina Milanesi said. “From fridges to ovens
RSS